FOXP3 Activation in Treg Cells, - Atomic Level Aspects of FOXP3 Structure and Biochemistry That Govern Function (89.4)

Bin Li,Xiaomin Song,Zhaocai Zhou,Qiang Wang,Yuan Shen,Mark I Greene
DOI: https://doi.org/10.4049/jimmunol.182.supp.89.4
2009-01-01
The Journal of Immunology
Abstract:Abstract The path by which signaling transduction from the cell surface to the nucleus leads to FOXP3 activation and function is undefined. The additional complexity of creation of an ordered FOXP3 ensemble of transcriptional cofactors on chromatin is not understood. FOXP3 activation in Treg cells may be regulated by extra-cellular stimuli that occur through innate, toll-like and cytokine receptors. Our studies found that TCR receptor and pro-inflammatory cytokine signals including TGF-beta and IL-6 regulate FOXP3 binding to DNA in human CD4+CD25+ Treg cells. Here we report our recent progress in understanding the role of cell surface receptor signals and pro-inflammatory cytokines in regulating biochemical modifications of the FOXP3 molecule altering its activity in Treg cells. We have now determined the biochemical features of how pro-inflammatory cytokines and pharmaceutical agents affect FOXP3 activity, and consequently how they may affect immune responses in human inflammatory disease. Moreover, we also have deduced the atomic structure of large parts of the FOXP3 molecule including the zinc finger and leucine zipper domains. These regions are important for dimerization and oligomerization of FOXP3 as well as interactions with other molecules. Our structural and biochemical studies establish the atomic and molecular basis for understanding human XLAAD/IPEX autoimmune diseases. Research grants include NIH AI073489-01A1 (M.I.G.) and Nidus Laboratories (B.L., and Z.Z.).
What problem does this paper attempt to address?